Alternatives to ImmuniQ

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Drug discovery and development company using a novel technological approach.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

AI-driven platform for protein-level disease mapping and drug discovery.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Biotechnology company developing novel therapies for multiple myeloma.

Omnix Medical is developing a novel platform for advanced wound care management.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Compressing biology to develop the next generation of therapies.

AI-powered insights platform for life sciences and biotech workflows.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Leveraging the adaptive immune system to diagnose and treat disease.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

A global oncology company developing and commercializing innovative cancer treatments.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

EU-based company providing personalized medicine solutions for medical practitioners.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-powered spatial biology platform for precision medicine and drug development.

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Developing novel therapeutic approaches for ocular diseases.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.